TechForce Robotics, Inc., the acting subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking the company's first operational entry into pharmaceutical and laboratory automation. The deployment fulfills Phase 1 objectives under a joint development agreement designed to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows.
A new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise that could support the expansion of high-precision AI-driven applications. Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries from manufacturing to hospitality: how to improve efficiency while freeing highly trained personnel to focus on higher-value work. Researchers, technicians, and production staff often spend significant time on routine logistics tasks that, while necessary, do not directly advance scientific work, product development, or manufacturing output. As labor costs rise and productivity demands grow, pharmaceutical and biotechnology organizations are exploring automation solutions capable of supporting operational scalability without disrupting tightly regulated workflows.
TechForce Robotics is positioning itself to address that opportunity by extending its Robotics-as-a-Service platform from hospitality into laboratory automation. The LIM-E robot is designed to handle routine material transport, sample delivery, and waste removal tasks within laboratory environments, potentially reducing the burden on skilled personnel. The company's approach leverages AI-enhanced systems to adapt to dynamic laboratory layouts and workflows, which could be critical for compliance with Good Manufacturing Practice (GMP) standards in pharmaceutical production.
The strategic alliance with JJ Enterprise brings additional capabilities in machine vision and precision engineering, which may accelerate the development of high-precision applications required for pharmaceutical automation. This partnership could enable TechForce to offer more sophisticated solutions that integrate with existing laboratory information management systems and automated equipment.
For more information about TechForce Robotics and its developments, visit the company's newsroom at https://ibn.fm/NGTF. This deployment represents a significant step for TechForce as it diversifies from its hospitality roots into the highly regulated pharmaceutical sector, where automation demand is growing amid workforce shortages and increasing productivity pressures.
